Published in Ann N Y Acad Sci on November 30, 1994
Structural and functional plasticity of the human brain in posttraumatic stress disorder. Prog Brain Res (2008) 1.59
Elevated risk for autoimmune disorders in iraq and afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry (2014) 1.50
Traumatic stress: effects on the brain. Dialogues Clin Neurosci (2006) 1.35
Comparing cortisol, stress, and sensory sensitivity in children with autism. Autism Res (2009) 1.33
Stress and brain atrophy. CNS Neurol Disord Drug Targets (2006) 0.99
Examining cortisol rhythmicity and responsivity to stress in children with Tourette syndrome. Psychoneuroendocrinology (2008) 0.94
Post-traumatic stress disorder and declarative memory functioning: a review. Dialogues Clin Neurosci (2011) 0.85
Amnesia for early life stress does not preclude the adult development of posttraumatic stress disorder symptoms in rats. Biol Psychiatry (2013) 0.82
Glucocorticoid-related predictors and correlates of post-traumatic stress disorder treatment response in combat veterans. Interface Focus (2014) 0.78
Neurobiological findings in posttraumatic stress disorder: a review. Dialogues Clin Neurosci (2000) 0.76
Onset, timing, and exposure therapy of stress disorders: mechanistic insight from a mathematical model of oscillating neuroendocrine dynamics. Biol Direct (2016) 0.75
New translational perspectives for blood-based biomarkers of PTSD: From glucocorticoid to immune mediators of stress susceptibility. Exp Neurol (2016) 0.75
Orexins Mediate Sex Differences in the Stress Response and in Cognitive Flexibility. Biol Psychiatry (2016) 0.75
Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse (2000) 1.98
Relationship between posttraumatic stress disorder characteristics of Holocaust survivors and their adult offspring. Am J Psychiatry (1998) 1.96
Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry (1996) 1.84
Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry (1989) 1.79
Genome scan of schizophrenia. Am J Psychiatry (1998) 1.74
Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry (1988) 1.64
Affective instability and impulsivity in borderline personality and bipolar II disorders: similarities and differences. J Psychiatr Res (2001) 1.62
Preliminary evidence of a serotonin (5-HT-1-like) component to the prolactin response to buspirone challenge in humans. Arch Gen Psychiatry (1990) 1.62
Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. Arch Gen Psychiatry (1997) 1.51
Sex differences in dopamine receptors and their relevance to ADHD. Neurosci Biobehav Rev (2000) 1.50
Side effects of light therapy in seasonal affective disorder. Am J Psychiatry (1993) 1.49
Learning and memory in combat veterans with posttraumatic stress disorder. Am J Psychiatry (1995) 1.44
Sex differences in dopamine receptor overproduction and elimination. Neuroreport (1997) 1.43
Three-dimensional analysis with MRI and PET of the size, shape, and function of the thalamus in the schizophrenia spectrum. Am J Psychiatry (1999) 1.43
Shape and size of the corpus callosum in schizophrenia and schizotypal personality disorder. Schizophr Res (2000) 1.41
Prevalence and stability of the DSM-III-R personality disorders in a community-based survey of adolescents. Am J Psychiatry (1993) 1.35
Depression, the immune system, and health and illness. Findings in search of meaning. Arch Gen Psychiatry (1991) 1.27
Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry (1985) 1.27
Seasonal mood disorders. Patterns of seasonal recurrence in mania and depression. Arch Gen Psychiatry (1993) 1.24
Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide. Mol Psychiatry (2007) 1.22
Suckling pheromone stimulation of a modified glomerular region in the developing rat olfactory bulb revealed by the 2-deoxyglucose method. Brain Res (1980) 1.21
Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am J Psychiatry (1998) 1.19
Developmental differences in dopamine synthesis inhibition by (+/-)-7-OH-DPAT. Naunyn Schmiedebergs Arch Pharmacol (1997) 1.18
Functional development of the olfactory bulb and a unique glomerular complex in the neonatal rat. J Neurosci (1982) 1.15
Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am J Med Genet (1996) 1.12
Suckling. Science (1980) 1.10
Magnetic resonance imaging of the thalamic mediodorsal nucleus and pulvinar in schizophrenia and schizotypal personality disorder. Arch Gen Psychiatry (2001) 1.09
Circadian locomotor activity rhythms in Alzheimer's disease. Neuropsychopharmacology (1991) 1.09
Are the interpersonal and identity disturbances in the borderline personality disorder criteria linked to the traits of affective instability and impulsivity? J Pers Disord (2001) 1.07
Ventricular volume and asymmetry in schizotypal personality disorder and schizophrenia assessed with magnetic resonance imaging. Schizophr Res (1997) 1.07
Temporal lobe volume determined by magnetic resonance imaging in schizotypal personality disorder and schizophrenia. Schizophr Res (2001) 1.05
Affective and impulsive personality disorder traits in the relatives of patients with borderline personality disorder. Am J Psychiatry (1991) 1.04
First suckling response of the newborn albino rat: the roles of olfaction and amniotic fluid. Science (1977) 1.02
Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder. Psychiatry Res (1995) 1.01
Classical conditioning of an odor preference in 3-day-old rats. Behav Neural Biol (1980) 1.00
Individual differences in posttraumatic stress disorder symptom profiles in Holocaust survivors in concentration camps or in hiding. J Trauma Stress (1997) 1.00
A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder. J Clin Psychiatry (2001) 0.98
Increased nocturnal activity and impaired sleep maintenance in abused children. J Am Acad Child Adolesc Psychiatry (1997) 0.97
Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry (2001) 0.95
Age-related changes in the association between serotonergic function and aggression in boys with ADHD. Biol Psychiatry (1997) 0.95
Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res (1997) 0.94
Attentional functioning in schizotypal personality disorder. Am J Psychiatry (1997) 0.94
Increased prevalence of electrophysiological abnormalities in children with psychological, physical, and sexual abuse. J Neuropsychiatry Clin Neurosci (1993) 0.93
Relationship between early abuse, posttraumatic stress disorder, and activity levels in prepubertal children. J Am Acad Child Adolesc Psychiatry (1996) 0.93
Plasma norepinephrine and 3-methoxy-4-hydroxyphenylglycol concentrations and severity of depression in combat posttraumatic stress disorder and major depressive disorder. Biol Psychiatry (1998) 0.93
Tryptophan hydroxylase genotype is associated with impulsive-aggression measures: a preliminary study. Am J Med Genet (1998) 0.92
The factor structure of schizotypal symptoms in a clinical population. Schizophr Bull (1996) 0.92
Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. Brain Res Dev Brain Res (1989) 0.91
Visuospatial working memory in schizotypal personality disorder patients. Schizophr Res (2000) 0.91
Enduring neurochemical effects of early maternal separation on limbic structures. Ann N Y Acad Sci (1999) 0.91
Serotonin laterality in amygdala predicts performance in the elevated plus maze in rats. Neuroreport (1999) 0.90
Preliminary evidence for aberrant cortical development in abused children: a quantitative EEG study. J Neuropsychiatry Clin Neurosci (1998) 0.90
Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder. Am J Psychiatry (1994) 0.90
Second generation antidepressants: a comparative review. J Clin Pharmacol (1985) 0.90
Relationship between depression and borderline personality disorder. Depress Anxiety (1999) 0.90
Brain T2 relaxation times correlate with regional cerebral blood volume. MAGMA (2004) 0.89
Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res (1994) 0.88
Neurotransmitter dysfunction in patients with borderline personality disorder. Psychiatr Clin North Am (2000) 0.88
Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res (1992) 0.88
Thought disorder in the meta-structure of psychopathology. Psychol Med (2012) 0.88
Event-related potentials in schizotypal personality disorder. J Neuropsychiatry Clin Neurosci (1996) 0.88
Evoked potential evidence for right brain activity during the recall of traumatic memories. J Neuropsychiatry Clin Neurosci (1995) 0.87
L-dopa challenge and relapse in schizophrenia. Am J Psychiatry (1987) 0.87
Effects of amphetamine on visuospatial working memory performance in schizophrenia spectrum personality disorder. Neuropsychopharmacology (2000) 0.87
Serotonin, aggression, and parental psychopathology in children with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (1997) 0.87
Impaired smooth pursuit eye movement: vulnerability marker for schizotypal personality disorder in a normal volunteer population. Am J Psychiatry (1984) 0.87
Regional cerebral blood flow during the Wisconsin Card Sort Test in schizotypal personality disorder. Schizophr Res (1997) 0.87
The search for a schizotype. Crossing the border again. Arch Gen Psychiatry (1983) 0.86
Suicide, impulsive aggression, and HTR1B genotype. Biol Psychiatry (2001) 0.86
Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Psychoneuroendocrinology (1996) 0.86
New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine. Biol Psychiatry (1984) 0.85
Suckling in newborn rats: eliminated by nipple lavage, reinstated by pup saliva. Science (1976) 0.85
Circadian rhythms of activity in healthy young and elderly humans. Neurobiol Aging (1989) 0.84
D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder. Schizophr Res (1996) 0.84
Serotonergic function and self-injurious behavior in personality disorder patients. Psychiatry Res (1997) 0.84
Depressive response to physostigmine challenge in borderline personality disorder patients. Neuropsychopharmacology (1997) 0.84
Olfactory bulb control of circadian activity rhythm in mice. Brain Res (1990) 0.83
New perspectives on schizotypal personality disorder. Curr Psychiatry Rep (2000) 0.83
Validity of the family history method for identifying schizophrenia-related disorders. Psychiatry Res (1997) 0.83
Decreasing sensitivity to neuroleptic agents in developing rats; evidence for a pharmacodynamic factor. Psychopharmacology (Berl) (1988) 0.83
Prolonged antidopaminergic actions of single doses of butyrophenones in the rat. Psychopharmacology (Berl) (1985) 0.83
Cortisol responses to mental arithmetic in acute and remitted depression. Biol Psychiatry (1991) 0.83
Effects of passive body heating on the sleep of older female insomniacs. J Geriatr Psychiatry Neurol (1996) 0.83
Electroencephalogram, bilateral ear temperature, and affect changes induced by lateral visual field stimulation. Compr Psychiatry (1999) 0.83
Smooth pursuit performance in patients with affective disorders or schizophrenia and normal controls: analysis with specific oculomotor measures, RMS error and qualitative ratings. Psychol Med (1995) 0.82
Altered locomotor activity in neuropsychiatric patients. Prog Neuropsychopharmacol Biol Psychiatry (1986) 0.82
Light visor treatment for seasonal affective disorder: a multicenter study. Psychiatry Res (1993) 0.82
Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans. Psychopharmacol Bull (1990) 0.82
Serum cholesterol and impulsivity in personality disorders. Psychiatry Res (1999) 0.82